Latest Tech News

Stay updated with the latest in technology, AI, cybersecurity, and more

Filtered by: semaglutide Clear Filter

Dietitian Tips for Fighting Food Noise -- Without Using Semaglutide

If you’ve ever found your mind consumed with constant thoughts about food, chances are you have experienced food noise. It's usually brought on by conflicting messages about nutrition, either through everyday conversation or content online. It could be feeling guilty because you ate a cupcake when you promised yourself you weren’t going to touch sweets for a while, or maybe you’re trying to meet your protein quota and are obsessively keeping track of it. These thoughts are common, and in some ca

How to Fight Food Noise if It’s Taking Over Your Life, Both IRL and Online

If you’ve ever found your mind consumed with constant thoughts about food, chances are you have experienced food noise. It's usually brought on by conflicting messages about nutrition, either through everyday conversation or content online. It could be feeling guilty because you ate a cupcake when you promised yourself you weren’t going to touch sweets for a while, or maybe you’re trying to meet your protein quota and are obsessively keeping track of it. These thoughts are common, and in some ca

Ozempic Maker Novo Nordisk Freezes Hiring Amid Ongoing Struggles

No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish pharmaceutical company has enacted a hiring freeze—the latest sign of a sinking financial outlook for the once-titan of the obesity treatment world. Reuters reported on the hiring freeze Wednesday. The company has faced numerous setbacks in recent months, including billions shaved off its stock market value and continued competition from cheaper, compounded versions of its bloc

Ozempic shows anti-aging effects in trial

The diabetes drug Ozempic has demonstrated remarkable anti-aging effects in the first clinical trial to directly measure its impact on biological aging, with participants becoming an average of 3.1 years biologically younger after 32 weeks of treatment. The findings provide the strongest evidence yet that GLP-1 drugs like semaglutide may offer benefits far beyond their established roles in diabetes management and weight loss. First Direct Clinical Evidence of Anti-Aging Effects Varun Dwaraka f

Ozempic Shows Anti-Aging Effects in Trial, Reversing Biological Age by 3.1 Years

The diabetes drug Ozempic has demonstrated remarkable anti-aging effects in the first clinical trial to directly measure its impact on biological aging, with participants becoming an average of 3.1 years biologically younger after 32 weeks of treatment. The findings provide the strongest evidence yet that GLP-1 drugs like semaglutide may offer benefits far beyond their established roles in diabetes management and weight loss. First Direct Clinical Evidence of Anti-Aging Effects Varun Dwaraka f

Ozempic Might Be a Dementia Buster, Too

Semaglutide, the active ingredient in popular weight loss drugs Ozempic and Wegovy, might also double as a brain booster. Research out today describes a link between semaglutide use and a reduced risk of dementia in people with type 2 diabetes. Scientists at Case Western Reserve University conducted the study, published in the Journal of Alzheimer’s Disease. They found that diabetes patients taking semaglutide have a significantly lower risk of dementia than those taking other diabetes medicati

Something Comically Bad Just Happened to the Inventor of Ozempic

Image by Kristian Tuxen Ladegaard Berg/SOPA Images/LightRocket via Getty Images / Futurism Rx/Medicines Novo Nordisk, the Danish company behind Ozempic and Wegovy, made one very dumb decision a few years ago that's now poised to massively eat into its profits — a wild twist in the pharma company's saga, and an all-time cautionary tale for its peers. When watching an interview with the head of generic drugmaker Sandoz, Science magazine columnist Derek Lowe learned something incredible: that Nov

Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage

Shares of Hims & Hers Health closed down around 26% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved. Semaglutide is the active ingredient in Novo Nordisk's blockbuster weight loss drug Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called GLP-1s, and demand for the treatments has exploded in recent years. As a result, digital health companies such as Hims & Hers have been

Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

Shares of Hims & Hers Health tumbled more than 23% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved. Semaglutide is the active ingredient in Novo Nordisk's blockbuster weight loss drugs Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called GLP-1s, and demand for the treatments has exploded in recent years. As a result, digital health companies like Hims & Hers have been pr